![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | A61K 31/135 | (2006.01) |
A61K 31/55 | (2006.01) | ||
A61P 3/04 | (2006.01) |
(11) | Number of the document | 1833473 |
(13) | Kind of document | T |
(96) | European patent application number | 05855247.2 |
Date of filing the European patent application | 2005-12-21 | |
(97) | Date of publication of the European application | 2007-09-19 |
(45) | Date of publication and mention of the grant of the patent | 2009-09-09 |
(46) | Date of publication of the claims translation | 2010-01-25 |
(86) | Number | PCT/US2005/046654 |
Date | 2005-12-21 |
(87) | Number | WO 2006/071740 |
Date | 2006-07-06 |
(30) | Number | Date | Country code |
638667 P | 2004-12-23 | US | |
688901 P | 2005-06-08 | US |
(72) |
BEHAN, Dominic P., US
SMITH, Brian M., US
BJENNING, Christina, US
|
(73) |
Arena Pharmaceuticals, Inc.,
6166 Nancy Ridge Drive, San Diego, CA 92121-3223,
US
|
(74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | 5HT2C receptoriaus moduliatoriaus kompozicijos ir jų panaudojimo būdai |
5HT2C RECEPTOR MODULATOR COMPOSITIONS AND METHODS OF USE |
Payment date | Validity (years) | Amount | |
2015-12-01 | 11 | 289.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2016-12-21 |